Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank78
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-11.94M
↑ 59% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-29.43M
Historical baseline
PeriodValueYoY Change
TTM$-11.94M+81.9%
2024$-65.92M-0.2%
2023$-65.76M-208.8%
2022$-21.30M+31.1%
2021$-30.91M+23.1%
2020$-40.18M-33.6%
2019$-30.08M-37.5%
2018$-21.88M-390.9%
2017$-4.46M-133.0%
2016$-1.91M-